Danielm Kerekes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

End-of-Life Treatment With Immunotherapy Increasing for Patients With Cancer

Those treated at nonacademic or low-volume facilities have higher odds of initiating therapy within one month of death. Those treated at nonacademic or low-volume facilities have higher odds of initiating therapy within one month of death.

New havenUnited statesYale universityDanielm kerekesHealthday news

End-of-life immunotherapy on the rise for patients with metastatic cancer

End-of-life immunotherapy on the rise for patients with metastatic cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Mindy valcarcelByjosh friedmanDanielm kerekesYale school of medicineNational cancer databaseYale school

Metastatic cancer patients more likely to survive at academic and high-volume hospitals when given immunotherapy: Study

Metastatic cancer patients more likely to survive at academic and high-volume hospitals when given immunotherapy: Study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesMario sznolSajid khanHoward formanAlexander freyHarriet klugerDaniel kerekesThuy tranRobert becherKelly olinoElizabeth prsicDanielm kerekesJames cluneTumors at yale school of medicineTeam science at yale centerYale department of surgery